Innospec Inc. (LON:0JAX)
London · Delayed Price · Currency is GBP · Price in USD 91.45
+2.00 (2.24%)
At close: Feb 11, 2026
Innospec Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 1,789 | 1,845 | 1,949 | 1,964 | 1,483 | 1,193 | |
Revenue Growth (YoY) | -4.49% | -5.31% | -0.76% | 32.38% | 24.33% | -21.16% |
Cost of Revenue | 1,288 | 1,303 | 1,358 | 1,377 | 1,049 | 850.4 |
Gross Profit | 501.2 | 542.9 | 591.1 | 586.7 | 434.9 | 342.7 |
Selling, General & Admin | 457 | 462.4 | 380.9 | 355.9 | 261.8 | 237 |
Research & Development | 46.2 | 47.8 | 41.7 | 38.7 | 37.4 | 30.9 |
Operating Expenses | 503.2 | 510.2 | 422.6 | 394.6 | 299.2 | 267.9 |
Operating Income | -2 | 32.7 | 168.5 | 192.1 | 135.7 | 74.8 |
Interest Expense | - | - | - | -1.1 | -1.5 | -1.8 |
Interest & Investment Income | 9.7 | 9.3 | 2.3 | - | - | - |
Currency Exchange Gain (Loss) | 7.1 | 4.9 | 3.6 | -6.4 | -1.6 | - |
Other Non Operating Income (Expenses) | -1.8 | -2.5 | - | - | - | 7.8 |
EBT Excluding Unusual Items | 13 | 44.4 | 174.4 | 184.6 | 132.6 | 80.8 |
Merger & Restructuring Charges | -0.9 | - | - | - | - | -21.3 |
Gain (Loss) on Sale of Assets | 0.2 | 0.2 | - | - | 1.8 | - |
Asset Writedown | -42 | - | - | - | - | -19.8 |
Other Unusual Items | 14.9 | -3.4 | - | - | - | - |
Pretax Income | -14.8 | 41.2 | 174.4 | 184.6 | 134.4 | 39.7 |
Income Tax Expense | -13.6 | 5.6 | 35.3 | 51.6 | 41.3 | 11 |
Net Income | -1.2 | 35.6 | 139.1 | 133 | 93.1 | 28.7 |
Net Income to Common | -1.2 | 35.6 | 139.1 | 133 | 93.1 | 28.7 |
Net Income Growth | - | -74.41% | 4.59% | 42.86% | 224.39% | -74.42% |
Shares Outstanding (Basic) | 25 | 25 | 25 | 25 | 25 | 25 |
Shares Outstanding (Diluted) | 25 | 25 | 25 | 25 | 25 | 25 |
Shares Change (YoY) | -0.70% | 0.39% | 0.16% | 0.52% | 0.30% | 0.21% |
EPS (Basic) | -0.05 | 1.43 | 5.60 | 5.37 | 3.78 | 1.17 |
EPS (Diluted) | -0.05 | 1.42 | 5.56 | 5.32 | 3.75 | 1.16 |
EPS Growth | - | -74.46% | 4.51% | 41.87% | 223.28% | -74.45% |
Free Cash Flow | 54.8 | 143.1 | 145.2 | 42.1 | 54.1 | 116.2 |
Free Cash Flow Per Share | 2.20 | 5.70 | 5.80 | 1.69 | 2.18 | 4.69 |
Dividend Per Share | 1.630 | 1.550 | 1.410 | 1.280 | 1.160 | 1.040 |
Dividend Growth | 10.13% | 9.93% | 10.16% | 10.35% | 11.54% | 1.96% |
Gross Margin | 28.01% | 29.42% | 30.33% | 29.88% | 29.32% | 28.72% |
Operating Margin | -0.11% | 1.77% | 8.65% | 9.78% | 9.15% | 6.27% |
Profit Margin | -0.07% | 1.93% | 7.14% | 6.77% | 6.28% | 2.40% |
Free Cash Flow Margin | 3.06% | 7.75% | 7.45% | 2.14% | 3.65% | 9.74% |
EBITDA | 42.7 | 75.8 | 207.4 | 231.8 | 178.1 | 120.4 |
EBITDA Margin | 2.39% | 4.11% | 10.64% | 11.80% | 12.01% | 10.09% |
D&A For EBITDA | 44.7 | 43.1 | 38.9 | 39.7 | 42.4 | 45.6 |
EBIT | -2 | 32.7 | 168.5 | 192.1 | 135.7 | 74.8 |
EBIT Margin | -0.11% | 1.77% | 8.65% | 9.78% | 9.15% | 6.27% |
Effective Tax Rate | - | 13.59% | 20.24% | 27.95% | 30.73% | 27.71% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.